Abstract:Background: Type 2 Diabetes (T2D) is a chronic metabolic disease characterized by hyperglycemia and carries a high risk of numerous complications. The rising prevalence of this lifelong condition affects millions globally, demanding novel therapeutic strategies. Existing medications targeting insulin and other pathways often pose limitations like suboptimal glycemic control, side effects, and high costs. Novel therapeutic targets are crucial for developing better treatments and potentially reducing side effects associated with previous drugs. Objective: This paper aims to comprehensively review and analyze potential targets for the treatment of diabetes mellitus. Method: We conducted a comprehensive search of MEDLINE, Scopus, Science Direct, PubMed, and Google Scholar databases. Search terms included “diabetes mellitus”, “novel targets”, “drug discovery”, “gene expression” and “molecular pathways”. We identified over 175 published articles exploring novel therapeutic targets for DM. Results: The review presented a detailed analysis of promising anti-diabetic targets. These targets encompass various pathways and mechanisms, including insulin signaling, Glucose signaling, inflammation and oxidative stress, gut microbiome, and epigenetic modifications. Several promising candidates emerged, such as Glucokinase activators, GPCRs modifiers, Fructose-1,6-bisphosphatase antagonists, Protein tyrosine phosphatase 1B antagonist, 11β-Hydroxysteroid, andDehydrogenase antagonists. Potential therapeutic agents targeting these emerging targets will be discussed, along with their mechanisms of action and preclinical/clinical evidence. Conclusion: By identifying and comprehensively analyzing new therapeutic targets, this review intends to provide insights for the development of more effective and efficient diabetes management strategies. The information presented can guide future research initiatives and drug development efforts toward novel and promising anti-diabetic therapies.

Exploring histone deacetylases in type 2 diabetes mellitus: pathophysiological insights and therapeutic avenues

Histone Deacetylases and Their Inhibitors: Molecular Mechanisms and Therapeutic Implications in Diabetes Mellitus

Histone deacetylases and inhibitors in diabetes mellitus and its complications

Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications

Novel histone post-translational modifications in diabetes and complications of diabetes: The underlying mechanisms and implications

Roles of histone deacetylase inhibitors in treatment of diabetes mellitus

Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.

Improving Insulin Sensitivity with HDAC Inhibitor.

Acetylated Histone Modifications: Intersection of Diabetes and Atherosclerosis

Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy

Comprehensive gene expression analysis of histone deacetylases and the transcription factor Nrf2 in the progression of diabetic nephropathy

Identification of Key Gene Pathways and Coexpression Networks of Islets in Human Type 2 Diabetes.

Genetic and Epigenetic Aspects of Type 1 Diabetes Mellitus: Modern View on the Problem

Search for Novel Therapeutic Targets of Type 2 Diabetes Mellitus

Epigenome-Wide Histone Acetylation Changes in Peripheral Blood Mononuclear Cells in Patients with Type 2 Diabetes and Atherosclerotic Disease

Gene Expression Profiling of Multiple Histone Deacetylases (HDAC) and Its Correlation with NRF2-Mediated Redox Regulation in the Pathogenesis of Diabetic Foot Ulcers

Molecular Pathology and Therapeutic Strategies of Type 2 Diabetes

Targeting neuronal PAS domain protein 2 and KN motif/ankyrin repeat domains 1: Advances in type 2 diabetes therapy

Autophagy modulators in type 2 diabetes: A new perspective

Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis

Histone Deacetylases in Metabolism: The Known and the Unexplored